Characterization of the pharmacokinetic disposition of levofloxacin in stallions after intravenous and intramuscular administration

Journal of Veterinary Pharmacology and Therapeutics

Volumn 31, Issue 5, 2008, Pages 399-405

  Goudah, A ^a   Abo El Sooud, K ^a   Shim, J H ^b   Shin, H C ^c   Abd El Aty, A M ^a,c  

^a Cairo University   (Egypt)

^b Chonnam National University   (South Korea)

^c Konkuk University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOFLOXACIN;

ANIMAL EXPERIMENT; ARTICLE; COMPARTMENT MODEL; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG PROTEIN BINDING; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STALLION;

ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; HALF-LIFE; HORSES; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; MALE; METABOLIC CLEARANCE RATE; OFLOXACIN; PROTEIN BINDING;

NEGIBACTERIA; POSIBACTERIA;

EID: 53149138975     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2008.00983.x     Document Type: Article

References (61)

1. Albarellos, G.A., Ambros, L.A. Landoni, M.F. (2005) Pharmacokinetics of levofloxacin after single intravenous and repeat oral administration to cats. Journal of Veterinary Pharmacology and Therapeutics, 28, 363 369.
2. Auten, G.M., Preheim, L.C., Sookpranee, M., Bittner, M.J., Sookpranee, T. Vibhagool, A. (1991) High-pressure liquid chromatography and microbiological assay of serum ofloxacin levels in adults receiving intravenous and oral therapy for skin infections. Antimicrobial Agents and Chemotherapy, 35, 2558 2561.
3. Bennett, J.V., Brodie, J.L., Benner, E.J. Kirby, W.M. (1966) Simplified, accurate method for antibiotic assay of clinical specimens. Applied Microbiology, 14, 170 177.
4. Bermingham, E.C., Papich, M.G. Vivrette, S.L. (2000) Pharmacokinetics of enrofloxacin administered intravenously and orally to foals. American Journal of Veterinary Research, 61, 706 709.
5. Böttcher, S., von Baum, H., Hoppe-Tichy, T., Benz, C. Sonntag, H.G. (2001) An HPLC assay and a microbiological assay to determine levofloxacin in soft tissue, bone, bile and serum. Journal of Pharmaceutical and Biomedical Analysis, 25, 197 203.
6. Bousquet-Melou, A., Bernard, S., Schneider, M. Toutain, P.L. (2002) Pharmacokinetics of marbofloxacin in horses. Equine Veterinary Journal, 34, 366 372.
7. Brown, S.A. (1996) Fluoroquinolones in animal health. Journal of Veterinary Pharmacology and Therapeutics, 19, 1 14.
8. Carretero, M., Rodríguez, C., San Andrés, M.I., Forés, P., de Lucas, J.J., Nieto, J., Waxman, S., San Andrés, M.D. González, F. (2002) Pharmacokinetics of marbofloxacin in mature horses after single intravenous and intramuscular administration. Equine Veterinary Journal, 34, 360 365.
9. Cheng, F.C., Tsai, T.R., Chen, Y.F., Hung, L.C. Tsai, T.H. (2002) Pharmacokinetic study of levofloxacin in rat blood and bile by microdialysis and high-performance liquid chromatography. Journal of Chromatography A, 961, 131 136.
10. Child, J., Mortiboy, D., Andrews, J.M., Chow, A.T. Wise, R. (1995) Open-label crossover study to determine pharmacokinetics and penetration of two dose regimens of levofloxacin into inflammatory fluid. Antimicrobial Agents and Chemotherapy, 39, 2749 2751.
11. Chulavatnatol, S., Chindavijak, B., Vibhagool, A., Wananukul, W., Sriapha, C. Sirisangtragul, C. (1999) Pharmacokinetics of levofloxacin in healthy Thai male volunteers. Journal of the Medical Association of Thailand, 82, 1127 1135.
12. Craig, W.A. (1998) Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clinical Infectious Diseases, 26, 1 10.
13. Craig, A.W. Suh, B. (1991) Protein binding and the antibacterial effects. Method for the determination of protein binding. In Antibiotics in Laboratory Medicine, 3rd edn, Ed. Lorian, V., pp. 367 402. Williams & Wilkins, Baltimore, MY, USA.
14. Czock, D., Hüsig-Linde, C., Langhoff, A., Schöpke, T., Hafer, C., de Groot, K., Swoboda, S., Kuse, E., Haller, H., Fliser, D., Keller, F. Kielstein, J.T. (2006) Pharmacokinetics of moxifloxacin and levofloxacin in intensive care unit patients who have acute renal failure and undergo extended daily dialysis. Clinical Journal of the American Society of Nephrology, 1, 1263 1268.
15. Davis, R. Bryson, H.M. (1994) Levofloxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy. Drugs, 47, 677 700.
16. Davis, J.L., Papich, M.G. Weingarten, A. (2006) The pharmacokinetics of orbifloxacin in the horse following oral and intravenous administration. Journal of Veterinary Pharmacology and Therapeutics, 29, 191 197.
17. Destache, C.J., Pakiz, C.B., Larsen, C., Owens, H. Dash, A.K. (2001) Cerebrospinal fluid penetration and pharmacokinetics of levofloxacin in an experimental rabbit meningitis model. Journal of Antimicrobial Chemotherapy, 47, 611 615.
18. Djabarouti, S., Boselli, E., Allaouchiche, B., Ba, B., Nguyen, A.T., Gordien, J.B., Bernadou, J.M., Saux, M.C. Breilh, D. (2004) Determination of levofloxacin in plasma, bronchoalveolar lavage and bone tissues by high-performance liquid chromatography with ultraviolet detection using a fully automated extraction method. Journal of Chromatography B, 799, 165 172.
19. Drlica, K. Zhao, X. (1997) DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiology and Molecular Biology Reviews, 61, 377 392.
20. Dumka, V.K. Srivastava, A.K. (2006) Pharmacokinetics, urinary excretion and dosage regimen of levofloxacin following a single intramuscular administration in cross bred calves. Journal of Veterinary Science, 7, 333 337.
21. Dumka, V.K. Srivastava, A.K. (2007) Disposition kinetics, urinary excretion and dosage regimen of levofloxacin formulation following single intravenous administration in crossbred calves. Veterinary Research Communications, 31, 873 879.
22. Edelstein, P.H., Edelstein, M.A., Lehr, K.H. Ren, J. (1996) In vitro activity of levofloxacin against clinical isolates of Legionella spp, its pharmacokinetics in guinea pigs, and use in experimental Legionella pneumophila pneumonia. Journal of Antimicrobial Chemotherapy, 37, 117 126.
23. Eliopoulos, G.M., Wennersten, C.B. Moellering, R.C. Jr (1996) Comparative in vitro activity of levofloxacin and ofloxacin against gram-positive bacteria. Diagnostic Microbiology and Infectious Disease, 25, 35 41.
24. Epstein, K., Cohen, N., Boothe, D., Nieuwoudt, C. Chandler, J. (2004) Pharmacokinetics, stability, and retrospective analysis of use of an oral gel formulation of the bovine injectable enrofloxacin in horses. Veterinary Therapeutics, 5, 155 167.
25. Ev Lda, S. Schapoval, E.E. (2002) Microbiological assay for determination of ofloxacin injection. Journal of Pharmaceutical and Biomedical Analysis, 27, 91 96.
26. Fernández-Varón, E., Ayala, I., Marín, P., Carrión, A., Martos, N., Escudero, E. Cárceles, C.M. (2006) Pharmacokinetics of danofloxacin in horses after intravenous, intramuscular and intragastric administration. Equine Veterinary Journal, 38, 342 346.
27. Fish, D.N. (2003) Levofloxacin: update and perspectives on one of the original 'respiratory quinolones'. Expert Review of Anti-infective Therapy, 1, 371 387.
28. Fish, D.N. Chow, A.T. (1997) The clinical pharmacokinetics of levofloxacin. Clinical Pharmacokinets, 32, 101 119.
29. Gardner, S.Y., Davis, J.L., Jones, S.L., Lafevers, D.H., Hoskins, M.S., Mcarver, E.M. Papich, M.G. (2004) Moxifloxacin pharmacokinetics in horses and disposition into phagocytes after oral dosing. Journal of Veterinary Pharmacology and Therapeutics, 27, 57 60.
30. Gibaldi, M. Perrier, D. (1982) Non Compartmental Analysis Based on Statistical Moment Theory. Pharmacokinetics, 2nd edn, Pp. 409 417. Marcel Dekker, New York.
31. Giguère, S., Sweeney, R.W. Bélanger, M. (1996) Pharmacokinetics of enrofloxacin in adult horses and concentration of the drug in serum, body fluids, and endometrial tissues after repeated intragastrically administered doses. American Journal of Veterinary Research, 57, 1025 1030.
32. Haddad, N.S., Pedersoli, W.M., Ravis, W.R., Fazeli, M.H. Carson, R.L. Jr (1985) Combined pharmacokinetics of gentamicin in pony mares after a single intravenous and intramuscular administration. American Journal of Veterinary Research, 46, 2004 2007.
33. Haines, G.R., Brown, M.P., Gronwall, R.R., Merritt, K.A. Baltzley, L.K. (2001) Pharmacokinetics of orbifloxacin and its concentration in body fluids and in endometrial tissues of mares. Canadian Journal of Veterinary Research, 65, 181 187.
34. Hurst, M., Lamb, H.M., Scott, L.J. Figgitt, D.P. (2002) Levofloxacin. An updated review of its use in the treatment of bacterial infections. Drugs, 62, 2127 2167.
35. Hyatt, J.M., McKinnon, P.S., Zimmer, G.S. Schentag, J.J. (1995) The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents. Clinical Pharmacokinetics, 28, 143 160.
36. Ito, T., Yano, I., Masuda, S., Hashimoto, Y. Inui, K. (1999) Distribution characteristics of levofloxacin and grepafloxacin in rat kidney. Pharmacological Research, 16, 534 539.
37. Kaartinen, L., Panu, S. Pyörälä, S. (1997) Pharmacokinetics of enrofloxacin in horses after single intravenous and intramuscular administration. Equine Veterinary Journal, 29, 378 381.
38. Klesel, N., Geweniger, K.H., Koletzki, P., Isert, D., Limbert, M., Markus, A., Riess, G., Schramm, H. Iyer, P. (1995) Chemotherapeutic activity of levofloxacin (HR 355, DR-3355) against systemic and localized infections in laboratory animals. The Journal of Antimicrobial Chemotherapy, 35, 805 819.
39. Langtry, H.D. Lamb, H.M. (1998) Levofloxacin. Its use in infections of the respiratory tract, skin, soft tissues and urinary tract. Drugs, 56, 487 515.
40. Lode, H., Borner, K. Koeppe, P. (1998) Pharmacodynamics of fluoroquinolones. Clinical Infectious Disease, 27, 33 39.
41. Marshall, S.A. Jones, R.N. (1993) In vitro activity of DU-6859a, a new fluorocyclopropyl quinolone. Antimicrobial Agents and Chemotherapy, 37, 2747 2753.
42. Martin, S.J., Meyer, J.M., Chuck, S.K., Jung, R., Messick, C.R. Pendland, S.L. (1998) Levofloxacin and sparfloxacin: new quinolone antibiotics. The Annals of Pharmacotherapy, 32, 320 336.
43. Martinez, M., McDermott, P. Walker, R. (2006) Pharmacology of the fluoroquinolones: a perspective for the use in domestic animals. The Veterinary Journal, 172, 10 28.
44. McKellar, Q., Gibson, I., Monteiro, A. Bregante, M. (1999) Pharmacokinetics of enrofloxacin and danofloxacin in plasma, inflammatory exudate, and bronchial secretions of calves following subcutaneous administration. Antimicrobial Agents and Chemotherapy, 43, 1988 1992.
45. Meinen, J.B., McClure, J.T. Rosin, E. (1995) Pharmacokinetics of enrofloxacin in clinically normal dogs and mice and drug pharmacodynamics in neutropenic mice with Escherichia coli and staphylococcal infections. American Journal of Veterinary Research, 56, 1219 1224.
46. Mochizuki, K., Ohkubo, S., Torisaki, M., Yamashita, Y., Tanahashi, T., Jin, Y., Okamura, Y. Tanaka, M. (1994) Intraoccular penetration of oral levofloxacin in rabbits. Nippon Ganka Gakkai Zasshi, 98, 1085 1090.
47. Norrby, S.R., Petermann, W., Willcox, P.A., Vetter, N. Salewski, E. (1998) A comparative study of levofloxacin and ceftriaxone in the treatment of hospitalized patients with pneumonia. Scandinavian Journal of Infectious Diseases, 30, 397 404.
48. North, D.S., Fish, D.N. Redington, J.J. (1998) Levofloxacin, a second-generation fluoroquinolone. Pharmacotherapy, 18, 915 935.
49. Papich, M.G., VanCamp, S.D., Cole, J. Whitacre, M.D. (2002) Pharmacokinetics and endometrial tissue concentrations of enrofloxacin and the metabolite ciprofloxacin after IV administration of enrofloxacin to mares. Journal of Veterinary Pharmacology and Therapeutics, 25, 343 350.
50. Park, S.C. Yun, H.I. (2003) Clinical pharmacokinetics of norfloxacin-glycine acetate after intravenous and intramuscular administration to horses. Research in Veterinary Science, 74, 79 83.
51. Peyrou, M., Bousquet-Mélou, A., Laroute, V., Vrins, A. Doucet, M.Y. (2006) Enrofloxacin and marbofloxacin in horses: comparison of pharmacokinetic parameters, use of urinary and metabolite data to estimate first-pass effect and absorbed fraction. Journal of Veterinary Pharmacology and Therapeutics, 29, 337 344.
52. Rebuelto, M., Otero, P., Albarellos, G., Ambros, L., Kreil, V., Waxman, S., Montoya, L. Hallu, R. (2000) Pharmacokinetics of fleroxacin in horses. Journal of Veterinary Pharmacology and Therapeutics, 23, 103 105.
53. Schentag, J.J. (1999) Antimicrobial action and pharmacokinetics/ pharmacodynamics: the use of AUIC to improve efficacy and avoid resistance. Journal of Chemotherapy, 11, 426 439.
54. Shah, P.M. Members of the International Study Group 1997) Levofloxacin Versus Cefuroxime Axetil in the Treatment of Acute Exacerbation of Chronic Bronchitis (abstract LM38), ICAAC, Toronto.
55. Spreng, M., Deleforge, J., Thomas, E., Boisrame, B. Drugeon, H. (1995) Antibacterial activity of marbofloxacin. A new fluoroquinolone for veterinary use against canine and feline isolates. Journal of Veterinary Pharmacology and Therapeutics, 18, 284 289.
56. Swoboda, S., Oberdorfer, K., Klee, F., Hoppe-Tichy, T., von Baum, H. Geiss, H.K. (2003) Tissue and serum concentrations of levofloxacin 500 mg administered intravenously or orally for antibiotic prophylaxis in biliary surgery. The Journal of Antimicrobial Chemotherapy, 51, 459 462.
57. Toutain, P.L., Del Castillo, J.R.E. Bousquet-Mélou, A. (2002) The pharmacokinetic-pharmacodynamic approach to a rational dosage regimen for antibiotics. Research in Veterinary Science, 73, 105 114.
58. Toutan, P.L. Bousquet-Melou, A. (2004) Volumes of distribution. Journal of Veterinary Pharmacology and Therapeutics, 27, 441 453.
59. Walker, R.D. (2000) The use of fluoroquinolones for companion animal antimicrobial therapy. Australian Veterinary Journal, 78, 84 90.
60. Wolfson, J.S. Hooper, D.C. (1989) Fluoroquinolone antimicrobial agents. Clinical Microbiology Reviews, 2, 378 424.
61. Yamaoka, K., Nakagawa, T. Uno, T. (1978) Statistical moment in pharmacokinetics. Journal of Pharmacokinetic and Biopharmaceutics, 6, 547 558.